TLQP 21 is a VGF-derived peptide, spans residues 556-576 of the precursor sequence. Protects cerebellar granule cells (CGCs) from serum and potassium deprivation-induced apoptosis. Increases energy expenditure and prevents early phase diet-induced diabetes.
TLQP 21, a bioactive peptide derived from the VGF protein precursor, has garnered significant attention in scientific research due to its diverse physiological roles and unique sequence features. As a member of the VGF-derived peptide family, TLQP 21 exhibits notable stability and bioactivity, making it a valuable tool in the exploration of complex biological pathways. Researchers are particularly interested in its capacity to modulate cellular signaling and metabolic processes, which has led to a surge in studies utilizing this peptide across multiple scientific disciplines. Its ability to interact with specific receptors and influence downstream effects further elevates its status as a versatile molecule for experimental applications. TLQP 21's synthetic accessibility and compatibility with various in vitro and in vivo models also contribute to its widespread adoption in advanced research settings.
Neurobiology research: In the field of neurobiology, TLQP 21 serves as a critical reagent for investigating neuronal signaling and synaptic plasticity. Scientists employ this peptide to probe its influence on neurotransmitter release, neuronal excitability, and the regulation of neuropeptide receptors. By applying TLQP 21 to cultured neurons or brain tissue preparations, researchers can delineate the intracellular signaling cascades activated upon peptide binding, shedding light on the mechanisms underlying synaptic modulation and neural communication. These studies are instrumental in advancing our understanding of cognitive functions, learning, and memory processes.
Metabolic regulation studies: TLQP 21 is extensively utilized in metabolic research to examine its effects on energy homeostasis and adipose tissue function. Experimental models, including primary adipocyte cultures and animal systems, benefit from the application of this peptide to elucidate its role in modulating lipid metabolism, glucose uptake, and thermogenic responses. Scientists leverage its capacity to interact with specific cell surface receptors, such as C3aR1, to dissect the signaling networks that govern metabolic activity and energy expenditure. These insights are crucial for unraveling the molecular basis of metabolic adaptation and obesity-related mechanisms.
Pain and nociception research: The peptide is increasingly recognized for its involvement in pain modulation and nociceptive signaling. Researchers utilize TLQP 21 in sensory neuron assays and in vivo pain models to investigate its capacity to influence pain perception and inflammatory responses. By examining changes in neuronal firing rates, ion channel activity, and neuropeptide release following peptide administration, investigators can better understand the pathways that contribute to pain sensitization and the endogenous mechanisms of pain regulation. Such studies provide a foundation for identifying novel targets in the field of pain research.
Endocrine function exploration: In studies focused on endocrine regulation, TLQP 21 is applied to explore its impact on hormone secretion and endocrine tissue responsiveness. Experimental protocols may involve the treatment of pituitary or pancreatic cell lines with the peptide to assess changes in hormone release and cellular signaling events. By mapping the downstream effects of TLQP 21 interaction with endocrine cells, researchers can gain valuable insights into the cross-talk between neuropeptide signaling and hormonal control, which is vital for understanding the integration of metabolic and endocrine functions.
Cellular signaling pathway analysis: The use of TLQP 21 extends to the detailed mapping of intracellular signaling pathways. Scientists employ this peptide in both cell-based assays and molecular studies to identify the activation of key kinases, second messenger systems, and transcriptional regulators. By tracking the temporal and spatial dynamics of signaling molecules following peptide exposure, researchers can elucidate the intricate networks that drive cellular responses to external stimuli. This approach not only enhances our knowledge of VGF-derived peptide function but also supports the development of new experimental models for signal transduction research.
In summary, TLQP 21 stands as an indispensable tool across a spectrum of research domains, including neurobiology, metabolic regulation, pain and nociception, endocrine function, and cellular signaling pathway analysis. Its multifaceted roles in modulating physiological processes and signaling networks continue to drive scientific innovation, supporting the discovery of novel mechanisms and advancing our understanding of complex biological systems.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More